Success Story: A Postdoctoral Researcher Achieves NIW Approval With Our Expert Support, With No RFE Issued

 

Client’s Testimonial:

“Very helpful. The news makes my day.”


On April 1st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Translational Research (Approval Notice).


General Field: Translational Research

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: East Asia

State of Residence at the Time of Filing: Midwestern US

Approval Notice Date: April 1st, 2025

Processing Time: 15 months, 28 days


Case Summary:

We are proud to announce the successful approval of a National Interest Waiver (NIW) petition for a postdoctoral researcher and is making significant contributions to the field of biomedical science.

Our client specializes in translational research, with a focus on uncovering disease mechanisms through advanced genetic and animal model studies. His work aims to improve the understanding and treatment of complex inherited conditions. At the time of filing, he was employed at a U.S. medical research institution, where he was engaged in studies involving inherited mutations and cardiac diseases. To support his NIW petition, we emphasized:

  • An outstanding publication record of 41 peer-reviewed journal articles and 1 first-authored book chapter;
  • 1,343 citations across his works;
  • A peer review history with at least 5 reviews for top medical journals.
We demonstrated the national importance of his endeavor, given the economic and healthcare burden of cardiovascular disease in the U.S. His work, which has been supported by American Heart Association (AHA) funding, has also produced multiple highly cited articles, including 7 publications ranked among the top 1–20% most cited in clinical medicine.

We congratulate him on this well-earned approval and look forward to his continued impact on advancing cardiac care.